Fortress Biotech, Inc. (NASDAQ:FBIOP – Get Free Report) was the recipient of a large increase in short interest in the month of July. As of July 31st, there was short interest totaling 840 shares, an increase of ∞ from the July 15th total of 0 shares. Based on an average daily volume of 8,927 shares, the short-interest ratio is presently 0.1 days.
Fortress Biotech Stock Performance
Shares of FBIOP traded down $0.45 during midday trading on Friday, hitting $18.66. The stock had a trading volume of 40,432 shares, compared to its average volume of 21,796. The company has a 50 day simple moving average of $19.52 and a two-hundred day simple moving average of $15.96. Fortress Biotech has a twelve month low of $6.27 and a twelve month high of $21.43.
About Fortress Biotech
Fortress Biotech, Inc (NASDAQ: FBIOP) is a biopharmaceutical company that acquires, develops and commercializes innovative therapeutics for the treatment of patients with serious diseases. Operating as a biotech accelerator, Fortress Biotech partners with experienced management teams to advance products from early-stage discovery through regulatory approval and commercial launch. Its diversified portfolio spans multiple therapeutic areas, including oncology, rare diseases, dermatology, ophthalmology and neuromuscular disorders.
The company’s business model centers on establishing and funding product-centric subsidiary companies, each focused on a specific drug candidate or therapy.
See Also
- Five stocks we like better than Fortress Biotech
- The Metals Company’s Big Bet Now Comes Down to a License
- OneSpaWorld Keeps Turning Cruise Demand Into Record Earnings
- Meta and Tesla Are Rebounding From Oversold Levels—Now What?
- AMG’s Alternatives Boom Powers Record Growth
Receive News & Ratings for Fortress Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fortress Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
